Neerjesh P, Rajkishor Singh, Vipender Singh Chopra, Dharti N, Kavita Dhar, and Sanjay Kumar Singh, “Would other oral hypoglycaemics persist as an adequate 1ST line add-on therapy to metformin in patients with type 2 diabetes mellitus? No, it’s time to refocus!”, World J Pharm Sci, vol. 3, no. 12, pp. 2444–2451, Dec. 2015.